William S. Oetting

6.1k total citations
142 papers, 4.3k citations indexed

About

William S. Oetting is a scholar working on Molecular Biology, Transplantation and Cell Biology. According to data from OpenAlex, William S. Oetting has authored 142 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 42 papers in Transplantation and 38 papers in Cell Biology. Recurrent topics in William S. Oetting's work include Renal Transplantation Outcomes and Treatments (42 papers), melanin and skin pigmentation (37 papers) and Biochemical Analysis and Sensing Techniques (32 papers). William S. Oetting is often cited by papers focused on Renal Transplantation Outcomes and Treatments (42 papers), melanin and skin pigmentation (37 papers) and Biochemical Analysis and Sensing Techniques (32 papers). William S. Oetting collaborates with scholars based in United States, United Kingdom and Poland. William S. Oetting's co-authors include Richard A. King, Pamala A. Jacobson, Ajay K. Israni, Arthur J. Matas, Scott C. Wildenberg, James P. Fryer, Marcia J. Brott, Thomas A. Sellers, Weihua Guan and D. Flanders and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

William S. Oetting

140 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William S. Oetting United States 36 1.4k 1.1k 984 746 723 142 4.3k
Daniel R. Salomon United States 49 2.5k 1.8× 228 0.2× 1.8k 1.8× 1.3k 1.7× 65 0.1× 152 8.1k
Chava Kimchi‐Sarfaty United States 26 3.3k 2.3× 148 0.1× 112 0.1× 1.1k 1.5× 155 0.2× 88 6.0k
Kurt Hirschhorn United States 50 3.2k 2.3× 317 0.3× 80 0.1× 3.5k 4.7× 322 0.4× 328 10.3k
Roy L. Walford United States 39 1.6k 1.1× 258 0.2× 65 0.1× 464 0.6× 258 0.4× 157 6.7k
Martin Blum Germany 51 5.5k 3.9× 627 0.5× 41 0.0× 2.1k 2.8× 81 0.1× 158 9.1k
Leonard D. Goldstein United States 33 3.1k 2.2× 102 0.1× 84 0.1× 366 0.5× 63 0.1× 76 5.4k
Eun Young Song South Korea 34 1.0k 0.7× 77 0.1× 255 0.3× 301 0.4× 125 0.2× 211 3.8k
Carmine Vacca Italy 44 1.7k 1.2× 88 0.1× 93 0.1× 598 0.8× 78 0.1× 74 9.6k
Sarah Hunt United Kingdom 28 3.9k 2.8× 209 0.2× 32 0.0× 4.1k 5.5× 129 0.2× 55 8.2k
Eun Young Choi South Korea 35 2.5k 1.8× 267 0.2× 27 0.0× 340 0.5× 115 0.2× 175 5.3k

Countries citing papers authored by William S. Oetting

Since Specialization
Citations

This map shows the geographic impact of William S. Oetting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William S. Oetting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William S. Oetting more than expected).

Fields of papers citing papers by William S. Oetting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William S. Oetting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William S. Oetting. The network helps show where William S. Oetting may publish in the future.

Co-authorship network of co-authors of William S. Oetting

This figure shows the co-authorship network connecting the top 25 collaborators of William S. Oetting. A scholar is included among the top collaborators of William S. Oetting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William S. Oetting. William S. Oetting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Kofahi, Mahmoud, Casey R. Dorr, Rory P. Remmel, et al.. (2024). Steroid–tacrolimus drug–drug interaction and the effect of CYP3A genotypes. British Journal of Clinical Pharmacology. 90(11). 2837–2848. 1 indexed citations
2.
Capps, Benjamin, Ruth Chadwick, Zohar Lederman, et al.. (2023). The Human Genome Organisation (HUGO) and a vision for Ecogenomics: the Ecological Genome Project. Human Genomics. 17(1). 115–115. 1 indexed citations
3.
Loftus, Stacie K., M. Gillis, Laura L. Baxter, et al.. (2023). Haplotype-based analysis resolves missing heritability in oculocutaneous albinism type 1B. The American Journal of Human Genetics. 110(7). 1123–1137. 8 indexed citations
4.
Jacobson, Pamala A., et al.. (2022). Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability. Pharmacogenomics. 23(16). 873–885. 3 indexed citations
5.
Shaked, Abraham, Bao‐Li Loza, Elisabet Van Loon, et al.. (2022). Donor and recipient polygenic risk scores influence the risk of post-transplant diabetes. Nature Medicine. 28(5). 999–1005. 27 indexed citations
6.
Schladt, David P., Baolin Wu, Weihua Guan, et al.. (2022). Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers. Clinical Transplantation. 37(4). e14893–e14893. 6 indexed citations
7.
Loftus, Stacie K., Dawn E. Watkins‐Chow, Laura L. Baxter, et al.. (2021). A custom capture sequence approach for oculocutaneous albinism identifies structural variant alleles at the OCA2 locus. Human Mutation. 42(10). 1239–1253. 7 indexed citations
8.
Nguyen, Tam T. T. N., David P. Schladt, Danielle Berglund, et al.. (2020). Pharmacogenomics in kidney transplant recipients and potential for integration into practice. Journal of Clinical Pharmacy and Therapeutics. 45(6). 1457–1465. 6 indexed citations
9.
Oetting, William S., David P. Schladt, Casey R. Dorr, et al.. (2019). Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A. Transplantation. 103(8). 1591–1602. 14 indexed citations
10.
Pulk, Rebecca, David P. Schladt, William S. Oetting, et al.. (2015). Multigene Predictors of Tacrolimus Exposure in Kidney Transplant Recipients. Pharmacogenomics. 16(8). 841–854. 29 indexed citations
11.
Sanghavi, Kinjal, Richard C. Brundage, Michael B. Miller, et al.. (2015). Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. The Pharmacogenomics Journal. 17(1). 61–68. 59 indexed citations
12.
Miller, Michael B., Saonli Basu, Julie M. Cunningham, et al.. (2012). The Minnesota Center for Twin and Family Research Genome-Wide Association Study. Twin Research and Human Genetics. 15(6). 767–774. 53 indexed citations
13.
Basu, Saonli, Wei Pan, & William S. Oetting. (2011). A Dimension Reduction Approach for Modeling Multi-Locus Interaction in Case-Control Studies. Human Heredity. 71(4). 234–245. 6 indexed citations
14.
He, Hua, William S. Oetting, Marcia J. Brott, & Saonli Basu. (2009). Pair-Wise Multifactor Dimensionality Reduction Method to Detect Gene-Gene Interactions in A Case-Control Study. Human Heredity. 69(1). 60–70. 13 indexed citations
15.
Oetting, William S., et al.. (2005). P gene mutations associated with oculocutaneous albinism type II (OCA2). Human Mutation. 25(3). 323–323. 48 indexed citations
16.
King, Richard A., Rebecca Willaert, Sarah Savage, et al.. (2003). MC1R Mutations Modify the Classic Phenotype of Oculocutaneous Albinism Type 2 (OCA2). The American Journal of Human Genetics. 73(3). 638–645. 62 indexed citations
17.
Young, Terri L., Shawn M. Ronan, Scott C. Wildenberg, et al.. (1998). A Second Locus for Familial High Myopia Maps to Chromosome 12q. The American Journal of Human Genetics. 63(5). 1419–1424. 200 indexed citations
18.
Wildenberg, Scott C., James P. Fryer, John M. Gardner, et al.. (1998). Identification of a Novel Transcript Produced by the Gene Responsible for the Hermansky–Pudlak Syndrome in Puerto Rico. Journal of Investigative Dermatology. 110(5). 777–781. 9 indexed citations
19.
Townsend, DeWayne, et al.. (1990). Purification and Characterization of Dopachrome Tautomerase (DT). Pigment Cell Research. 3(S2). 32–35. 4 indexed citations
20.
Spritz, Richard A., Kathleen M. Strunk, William S. Oetting, & Richard A. King. (1988). RFLP for TaqI at the human tyrosinase locus. Nucleic Acids Research. 16(20). 9890–9890. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel R. Salomon Breakdown of academic impact, for papers by Chava Kimchi‐Sarfaty Breakdown of academic impact, for papers by Kurt Hirschhorn Breakdown of academic impact, for papers by Roy L. Walford Breakdown of academic impact, for papers by Martin Blum Breakdown of academic impact, for papers by Leonard D. Goldstein Breakdown of academic impact, for papers by Eun Young Song Breakdown of academic impact, for papers by Carmine Vacca Breakdown of academic impact, for papers by Sarah Hunt Breakdown of academic impact, for papers by Eun Young Choi
Rankless by CCL
2026